# Kevin Raidy

> Kevin Raidy is a Series B investor at Blue Owl backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Blue Owl](https://shizune.co/investors/profile/blue-owl-e2cf)
- Total investments: 1
- Last investment: Mar 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kevin-raidy-a1b24a33a

Kevin Raidy is a senior managing director at Blue Owl Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Latigo Biotherapeutics | Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependenceor tolerability. | $150M | Series B | Mar 17, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 2 deals together
- [Westlake Village BioPartners](https://shizune.co/investors/profile/westlake-village-biopartners) — VC Fund, 2 deals together
- [5AM Ventures](https://shizune.co/investors/profile/5am-ventures) — VC Fund, 1 deal together
- [Access Biotechnology](https://shizune.co/investors/profile/access-biotechnology) — VC Fund, 1 deal together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 1 deal together

## About Blue Owl

VC Fund · New York, United States

Blue Owl Capital is an alternative asset manager that provides investors access to direct lending and GP capital solutions strategies through a variety of vehicles. The firm's breadth of offerings and permanent capital base enables it to offer a differentiated, holistic platform of capital solutions to participants throughout the privatemarket ecosystem, including alternative asset managers and private middle market corporations.

5 contacts available at Blue Owl.

| Name | Title | Profile |
| --- | --- | --- |
| Darragh O’Flaherty | Principal | https://shizune.co/investors/profile/darragh-o-flaherty-fab5 |
| Kevin Raidy | Senior Managing Director | https://shizune.co/investors/profile/kevin-raidy-f74e |
| Marc Lipschultz | Co-CEO | https://shizune.co/investors/profile/marc-lipschultz |
| Alan Kirshenbaum | CFO | https://shizune.co/investors/profile/alan-kirshenbaum-8aa3 |
| Alicia Gregory | Managing Director | https://shizune.co/investors/profile/alicia-gregory |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Kevin Raidy invest in?

Kevin Raidy invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kevin Raidy last invest?

The most recent investment recorded for Kevin Raidy closed in Mar 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co